• Aucun résultat trouvé

The Biomedical Ontology Applications (BOA) Framework

N/A
N/A
Protected

Academic year: 2022

Partager "The Biomedical Ontology Applications (BOA) Framework"

Copied!
2
0
0

Texte intégral

(1)

!"#$%&'(#)&*+,$-./','01$

233,&*+/&'.4$5%-26$78+(#9'8:!

"#$%&!'()(#*+,!-$.&!/0!"(+1&+,!2(%3*4!5(#3(,!6&7&!20!5*##*3#(,!

'3(.&!8#*.&,!9(13(!/*+:$31(,!5#(%;3+;&!<0!9&$1&!

5(;$41=!&>!?;3*%;*+,!@%3)*#+31=!&>!A3+B&(,!/&#1$.(4!

2;4/8+*/<$'C*!"3&D*E3;(4!F%1&4&.=!GHH43;(13&%+!I"FGJ!>#(D*K&#L!;&%+3+1+!&>!(!+*1!&>!K*B!

(HH43;(13&%+! 1C(1! (3D! (1! (%! *>>*;13)*! *MH4&#(13&%! &>! B3&4&.3;(4! 3%>&#D(13&%! (%E! L%&K4*E.*!

E3+;&)*#=! $+3%.! "3&D*E3;(4! F%1&4&.3*+0! 'C3+! H(H*#! H#*+*%1+! 1C#**! "FG! K*B! (HH43;(13&%+N!

/#&1*O%F%!>&#!+*D(%13;!+3D34(#31=!(%E!H#&1*3%!+*1!;C(#(;1*#3P(13&%!B(+*E!&%!8*%*!F%1&4&.=!

I8FJQ! 9</?3D! >&#! +*D(%13;! +3D34(#31=! &>! ;C*D3;(4! ;&DH&$%E+! (%E! D*1(B&43;! H(1CK(=+!

$+3%.!1C*!9C*D3;(4!R%1313*+!&>!"3&4&.3;(4!O%1*#*+1!I9CR"OJ!&%1&4&.=Q!(%E!8ST5@U!>&#!1C*!

)3+$(43P(13&%,!>341*#3%.!(%E!(%(4=+3+!&>!8F!>$%;13&%(4!(%%&1(13&%!H#&>34*+!&>!(!.3)*%!H#&1*3%!

>(D34=0!'C*!K*B!1&&4+!(%E!1C*3#!E&;$D*%1(13&%,!3%;4$E3%.!)3E*&+,!(#*!>#**4=!()(34(B4*!>#&D!

C11HNVVM4EB0E30>;0$40H1VK3L3V"FG! !

=#19'8)4>$"3&D*E3;(4!F%1&4&.3*+,!?*D(%13;!?3D34(#31=,!W*B!GHH43;(13&%+! !

?$ $@./8')A*/&'.$ !

'C*! "3&D*E3;(4! F%1&4&.=! GHH43;(13&%+! I"FGJ!

>#(D*K&#L! 3%1*.#(1*+! B3&D*E3;(4! &%1&4&.3*+!

(%E! E(1(B(+*+! K31C! (! %$DB*#! &>! (4.&#31CD+!

(%E! )3+$(43P(13&%! 1&&4+,! >&;$+3%.! &%! &%1&4&.=X!

B(+*E!+*D(%13;!+3D34(#31=0!'C*!"FG!K*B!1&&4+,!

/#&1*O%F%,! 9</?3D! (%E! 8ST5@U,! (#*!

3%1*#;&%%*;1*E,!(%E!;$##*%14=!+$HH&#1!>$%;13&%(4!

(%(4=+*+!1C(1!*%;&DH(++!;C*D3;(4!;&DH&$%E+,!

.*%*!H#&E$;1+!(%E!D*1(B&43;!H(1CK(=+0! !

B$ $%-2$C#;$!'',4$ !

/#&1*O%F%! I/#&1*3%! O%1*#(;13&%+! Y! F%1&4&.=J!

3%1*.#(1*+!E(1(!>#&D! 1C*! 8*%*!F%1&4&.=!I8FJ!

Z[\,!8FG,!O%1G;1!Z]\!(%E!@%3/#&1!Z^\!E(1(B(+*+0!

O1!H#&)3E*+!*3.C1!8FXB(+*E!+*D(%13;!+3D34(#31=!

D*(+$#*+!Z_,`\!1C(1!;(%!B*!(HH43*E!1&!H#&1*3%+!

&#! 8F! 1*#D+! (;#&++! 1C*! 1C#**! 8F! (+H*;1+0! O1!

(4+&! +$HH&#1+! 1C*! 3E*%13>3;(13&%! &>! 1C*! D&+1!

D*(%3%.>$4! >$%;13&%(4! (%%&1(13&%+! &>! (! .3)*%!

+*1! &>! H#&1*3%+,! B(+*E! &%! 1C*! H#&B(B3431=! &>!

(%%&1(13&%!&>!*(;C!8F!1*#D,!(%E!1C*!#*1#3*)(4!

&>! 3%1*#(;13%.! H#&1*3%+0! 'C*! 3%1*.#(13&%! &>!

1C*+*!>*(1$#*+!+$HH&#1+!;&DH4*M!(%(4=+3+!+$;C!

(+!;(%E3E(1*!.*%*!3E*%13>3;(13&%!Za\0! !

9</?3D! I9C*D3;(4! (%E! <*1(B&43;!

/(1CK(=! ?3D34(#31=J! $+*+! 1C*! 9CR"O!

I9C*D3;(4! R%1313*+! &>! "3&4&.3;(4! O%1*#*+1J! Zb\!

&%1&4&.=! 1&! ;(4;$4(1*! +*D(%13;! +3D34(#31=!

B*1K**%!;C*D3;(4!;&DH&$%E+!(%E!(4+&!B*1K**%!

H(1CK(=+! >#&D! 1C*! c=&1&! R%;=;4&H*E3(! &>!

8*%*+!(%E!8*%&D*+!IcR88J!Zd\!B=!;&DH(#3%.!

1C*!+*1+!&>!9CR"O!1*#D+!(++&;3(1*E!K31C!1C*D0!

'C*! 3%1*.#(13&%! &>! 9CR"OXB(+*E! +*D(%13;!

+3D34(#31=!C(+!B**%!+C&K%!1&!3DH#&)*!*M3+13%.!

;C*D3;(4!;&DH&$%E!;4(++3>3;(13&%! +=+1*D+!Ze\0!

9</?3D! 3+! (4+&! (B4*! 1&! >3%E! 1C*! D&+1! D*(X

%3%.>$4!;C*D3;(4!;&DH&$%E!;4(++*+!3%!(!+*1!&>!

H(1CK(=+,!C3.C43.C13%.!1C*3#!;&DD&%!H#&H*#13*+0! ! 8ST5@U!I8S(HC!(%(4TP*#!&>!5@U;13&%(4!

(%%&1(13&%J! +$HH&#1+! 1C*! )3+$(43P(13&%! &>!

>$%;13&%(4! H#&>34*+! &>! H#&1*3%! +*1+0! 'C*+*!

H#&>34*+! (#*! +1#$;1$#*E! (+! +$B.#(HC+! &>! 8F,!

+C&K3%.!1C*!1*#D+!(%%&1(1*E!1&!1C*!H#&1*3%!+*1!

(%E! (44&K3%.! (! .4&B(4! )3*K! &>! 31+! >$%;13&%(4!

B#&(E%*++! (%E! +H*;3>3;31=0! 'C*=! (4+&! H#&)3E*!

E*1(34*E! +1(13+13;+! (%E! #*4*)(%1! D*1#3;+! B=!

3%1*.#(13%.! E(1(! >#&D! 8F! (%E! @%3/#&1,! (%E!

+$HH&#1!1C*!+*4*;13&%!&>!H#&1*3%!+$B+*1+!+C(#3%.!

(! +H*;3>3;! H#&>34*0! 8ST5@U! 3+! ;$##*%14=!

#*+1#3;1*E! 1&! (! E(1(+*1! &>! ;(#B&C=E#(1*X(;13)*!

*%P=D*+0! !

$

$

,&%2,QWHUQDWLRQDO&RQIHUHQFHRQ%LRPHGLFDO2QWRORJ\

-XO\ā%XIIDOR1<86$

(2)

!"#$%&'()*+($,-.!

"#$%! &'()! &*%! +*(,$*--.! %/++'(,01! 2.! ,#0!

3/41*56'!+*(*!*!7$849$*!0!"094'-':$*!,#('/:#!

,#0! ;/-,$*44/*-! 3/41$4:! <(':(*==0! *41!

:(*4,%>!

?3@ABCDBEFGFGBEHHIJ!?3@ABCDBKIHLMBEHHGJ!

?3@ABCDBNENOLBEHHGJ!?3@ABCDBNOHKMBEHHOJ!

*41!?3@ABCDBIFKNMBEHLHP!

Q,! &*%! *-%'! %/++'(,01! 2.! ,#0! R/('+0*4!

7'==$%%$'4! ,#('/:#! ,#0! R<QST@U! +('V09,!

/410(!,#0!3<G!WX(*4,!YEKLOHGZP! ! /(0(1($"(-!

LP "#0! X040! T4,'-':.! 7'4%'(,$/=P! X040!

T4,'-':.>! ,''-! ['(! ,#0! /4$[$9*,$'4! '[! 2$'-':.P!

\*,/(0!X040,$9%P!EMJ!EHLHJ!++P!EM²EFP! !

EP ](*41*J!CPJ!]9#/,#*4J!<PJ!]-*=^3*(/_/0J!`PJ!0,!

*-P>!"#0!Q4,]9,!='-09/-*(!$4,0(*9,$'4!1*,*2*%0P!

\/9-0$9! ]9$1%! @0%0*(9#P! EHLHJ! a'-P! KOJ! ++P!

DMEM^DMKLJ!WEHLHZP! !

KP "#0! b4$<(',! 7'4%'(,$/=P! "#0! b4$c0(%*-!

<(',0$4! @0%'/(90! Wb4$<(',ZP! \/9-0$9! ]9$1%!

@0%0*(9#P!EHLHJ!c'-P!KOJ!++P!DLNE^DLNOJ!WEHLHZP!

NP <0%_/$,*J!7PJ!3*($*J!DPJ!C*%,'%J!APJ!30((0$(*J!]PJ!

3*-9*'J! ]PJ! 7'/,'J! 3P>! ;0,($9%! ['(! XT! 2*%01!

+(',0$4! %0=*4,$9! %$=$-*($,.>! *! %.%,0=*,$9!

0c*-/*,$'4P! C;7! 2$'$4['(=*,$9%J! FW?MZJ! ?NJ!

WEHHOZP!

MP <0%_/$,*J!7PJ!3*($*J!DPJ!3*-96'J!]P!TPJ!d'(1J!<PJ!

7'/,'J!3P!;P>!?0=*4,$9!%$=$-*($,.!$4!2$'=01$9*-!

'4,'-':$0%P! <d'?! 7'=+/,*,$'4*-! C$'-':.J! MWGZJ!

WEHHFZP! !

IP C*%,'%J! A<J! "*c*(0%! CJ! <0%_/$,*! 7J! 3*($*! DJ!

7'/,'! 3;>! ]++-$9*,$'4! '[! X040! T4,'-':.! ,'!

X040! Q104,$[$9*,$'4! Q4! ?$-$9'! "''-%! ['(! X040!

D$%9'c0(.P!?+($4:0(J!WEHLLZP! !

GP D0:,.*(04)'J! UPJ! ;*,'%J! <PJ! R44$%J! ;PJ! 0,! *-P!

7#RCQ>! *! 1*,*2*%0! *41! '4,'-':.! ['(! 9#0=$9*-!

04,$,$0%! '[! 2$'-':$9*-! $4,0(0%,P! \/9-0$9! *9$1%!

(0%0*(9#P!WEHHGZP! !

OP U*40#$%*J!;PJ!X','J!?PJ!A*,,'($J!;PJ!0,!*-P>!3('=!

:04'=$9%!,'!9#0=$9*-!:04'=$9%>!40&!10c0-'+=04,%!

$4!URXXP!\/9-0$9!*9$1%!(0%0*(9#P!EHHIJ!a'-P!KNJ!

+P!DKMNJ!WEHHIZP! !

FP 30((0$(*J! eP! DPJ! 7'/,'J! 3P! ;P>! ?0=*4,$9!

?$=$-*($,.! ['(! ]/,'=*,$9! 7-*%%$[$9*,$'4! '[!

7#0=$9*-! 7'=+'/41%P! <d'?! 7'=+/,*,$'4*-!

C$'-':.J!IWFZJ!WEHLHZP!

! !

Références

Documents relatifs

With well-established ontologies now availa- ble in the OBO community, we are able to adapt the EFO approach to build the Beta Cell Genomics Ontology (BCGO) by

Once reconciliation candidates are identified (previous section), experts of the phenotype ontologies involved try to identify a common pattern for representing definitions, for

For external evaluation, other metrics can be useful to provide a quantitative overview, such as number of classes, properties in the ontology, or number of projects

The EMBL-EBI has recently developed a new version of the Ontology Lookup Service 4 (OLS) that includes DIACHRON functionality for archiving and executing change

SEBI incorporates a variety of knowledge infrastructure components and services including image feature extraction [5], semantic web data services [6], linked open data

On this basis, a curriculum of 16 modules was developed to train students in the biomedical domain with a back- ground in computer sciences how to practically develop and

The CORE problem list subset of SNOMED CT [6] was used as signature in the domain of diseases to find related drugs in RxNorm, using NDF-RT as a cross-ontology, and the

[r]